(Q53034300)

10 May 2018

title

Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. (English)

1 reference

10 May 2018

author

Jeffrey B. Kopp

7

1 reference

10 May 2018

Chunling Li

5

object named as

Chunling Li

1 reference

10 May 2018

Weidong Wang

1

object named as

Weidong Wang

1 reference

10 May 2018

author name string

Liru Qiu

2

1 reference

10 May 2018

Allison Howard

3

1 reference

10 May 2018

Nathaniel Solis

4

1 reference

10 May 2018

Xiaoxin Wang

6

1 reference

10 May 2018

Moshe Levi

8

1 reference

10 May 2018

publication date

16 July 2014

1 reference

10 May 2018

Journal of the Renin-Angiotensin-Aldosterone System

published in

1 reference

10 May 2018

volume

15

1 reference

10 May 2018

issue

4

1 reference

10 May 2018

page(s)

384-395

1 reference

10 May 2018

The renin–angiotensin system and diabetes: An update

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

An update on the lipid nephrotoxicity hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Proteinuria in diabetic kidney disease: a mechanistic viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Functional expression of the renin-angiotensin system in human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

The renin-angiotensin-aldosterone system in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Functional renin receptors in renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Nuclear hormone receptors in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Cellular lipid metabolism and the role of lipids in progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Proteinuria and hyperglycemia induce endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

CHOP deficiency results in elevated lipopolysaccharide-induced inflammation and kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320313507123

21 January 2018

Identifiers

DOI

10.1177/1470320313507123

1 reference

10 May 2018

1 reference

10 May 2018